This site is intended for healthcare professionals
News

Phase III trial with Ninlaro meets primary endpoint as first line maintenance treatment of multiple myeloma.- Takeda

Read time: 1 mins
Last updated:15th Jun 2020
Published:13th Jun 2020
Condition: Multiple Myeloma
Type: drug
Register free for full access to medthority.com